|
Applied Gene Technologies, Inc. |
|
|
6190 Cornerstone Ct. E. Ste. 101 San Diego, CA 92121 USA phone:(858) 452-6480 fax:(858) 452-7157
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.appliedgene.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Nucleic acid based products for diagnosis of infectious diseases and cancer. |
 |
| Management |
| Nani Dattagupta, Ph.D., President & Chief Scientific Officer; C. N. Sridhar, Ph.D., Chief Operating Officer; Whei-Kuo Wu, Ph.D., Vice President, Microbiology |
| |
|
|
| |
|
| Keywords |
| nucleic acid, infectious disease, cancer, point-of-care, DNA diagnostic product, InfectiousDisease |
|
|
|
| Description |
|
Applied Gene Technologies is focused on developing, manufacturing, and marketing novel nucleic acid based products for diagnosis of infectious diseases and cancer. |
 |
| Technology / Differentiation |
| Tessera Array Technology is a broad based platform technology and has use in high throughput drug discovery and drug screening applications. In addition, our technologies can be formatted to fit in point-of-care (POC), in the field or lab on a chip environment. |
 |
 |
|
|
|
|
|
|